Already a member? Sign in
Category: Prescription Drugs
Most Popular Types: BuTrans Transdermal Patch, Buprenorphine transdermal patch, Norspan patch (Show all)
Generic Name: Buprenorphine
Buprenorphine is an opioid analgesic used in the management of moderate to severe pain. It is also used in the treatment of opioid dependence. Off label it is used for heroin and opioid withdrawal.
| Purpose | # of patients |
# of patients with evaluations
Efficacy
|
Major | Moderate | Slight | None | Can’t tell |
|---|---|---|---|---|---|---|---|
| Pain | 35 | 16 |
|
|
|
|
|
| Fibromyalgia | 15 | 8 |
|
|
|
||
| Doctor recommendation | 9 | 3 |
|
|
|
||
| Chronic Pain Syndrome | 2 | 1 |
|
||||
| Neck pain | 2 | 0 | |||||
| Drug Addiction | 2 | 1 |
|
See all 52 patients currently taking Buprenorphine
Mouse over the table for more information
Commonly reported side effects, conditions, and hospitalizations associated with Buprenorphine
| Constipation | 4 | |
|---|---|---|
| Nausea | 3 | |
| Skin irritation | 2 | |
| Dizziness | 2 | |
| Itching (pruritus) | 2 | |
| Insomnia | 2 | |
| See all 34 reported side effects ▼ | ||
Frequently reported dosages based on patients currently taking Buprenorphine. See all 28 dosages ►
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
| Side effects too severe | 9 | ||
| Did not seem to work | 5 | ||
| Doctor's advice | 3 | ||
| Other | 3 | ||
| Expense | 1 | ||
| Course of treatment ended | 1 |
Adherence
Taking treatment as prescribed
Adherence of Buprenorphine
Always |
26 | 90% |
|
|---|---|---|---|
Usually |
3 | 10% |
|
Sometimes |
0 | 0% |
|
Never |
0 | 0% |
|
Burden
Difficulty being on treatment
Burden of Buprenorphine
Very |
2 | 7% |
|
|---|---|---|---|
Somewhat |
2 | 7% |
|
A little |
6 | 21% |
|
Not at all |
19 | 66% |
|
Cost
Paid out of pocket
Cost of Buprenorphine
$200+ |
1 | 5% |
|
|---|---|---|---|
$100-199 |
1 | 5% |
|
$50-99 |
2 | 10% |
|
$25-49 |
3 | 14% |
|
< $25 |
14 | 67% |
|
See more information, including instructions, precautions, side effects, and interactions.
Report created on May 26, 2012.